Logo image of AIM.CA

AIMIA INC (AIM.CA) Stock Fundamental Analysis

TSX:AIM - Toronto Stock Exchange - CA00900Q1037 - Common Stock - Currency: CAD

2.43  -0.02 (-0.82%)

Fundamental Rating

4

Taking everything into account, AIM scores 4 out of 10 in our fundamental rating. AIM was compared to 34 industry peers in the Chemicals industry. While AIM seems to be doing ok healthwise, there are quite some concerns on its profitability. AIM shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

AIM had negative earnings in the past year.
In the past year AIM has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: AIM reported negative net income in multiple years.
AIM had negative operating cash flow in 4 of the past 5 years.
AIM.CA Yearly Net Income VS EBIT VS OCF VS FCFAIM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B

1.2 Ratios

With a Return On Assets value of -9.58%, AIM perfoms like the industry average, outperforming 54.84% of the companies in the same industry.
The Return On Equity of AIM (-17.24%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -9.58%
ROE -17.24%
ROIC N/A
ROA(3y)8.54%
ROA(5y)43.4%
ROE(3y)4.19%
ROE(5y)52.97%
ROIC(3y)N/A
ROIC(5y)N/A
AIM.CA Yearly ROA, ROE, ROICAIM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 200

1.3 Margins

AIM's Gross Margin of 27.11% is amongst the best of the industry. AIM outperforms 83.87% of its industry peers.
In the last couple of years the Gross Margin of AIM has declined.
AIM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.11%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-22.29%
AIM.CA Yearly Profit, Operating, Gross MarginsAIM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5K 10K

5

2. Health

2.1 Basic Checks

AIM does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AIM has been increased compared to 1 year ago.
Compared to 5 years ago, AIM has less shares outstanding
Compared to 1 year ago, AIM has a worse debt to assets ratio.
AIM.CA Yearly Shares OutstandingAIM.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M
AIM.CA Yearly Total Debt VS Total AssetsAIM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

2.2 Solvency

Based on the Altman-Z score of -1.79, we must say that AIM is in the distress zone and has some risk of bankruptcy.
AIM has a Altman-Z score of -1.79. This is in the lower half of the industry: AIM underperforms 70.97% of its industry peers.
AIM has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
AIM has a better Debt to Equity ratio (0.32) than 61.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Altman-Z -1.79
ROIC/WACCN/A
WACC8.12%
AIM.CA Yearly LT Debt VS Equity VS FCFAIM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M 600M

2.3 Liquidity

AIM has a Current Ratio of 2.73. This indicates that AIM is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.73, AIM belongs to the best of the industry, outperforming 80.65% of the companies in the same industry.
AIM has a Quick Ratio of 2.06. This indicates that AIM is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.06, AIM belongs to the top of the industry, outperforming 80.65% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 2.06
AIM.CA Yearly Current Assets VS Current LiabilitesAIM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

7

3. Growth

3.1 Past

AIM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 49.47%, which is quite impressive.
The Revenue has grown by 133.58% in the past year. This is a very strong growth!
The Revenue has been growing by 11.75% on average over the past years. This is quite good.
EPS 1Y (TTM)49.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.08%
Revenue 1Y (TTM)133.58%
Revenue growth 3Y340.8%
Revenue growth 5Y11.75%
Sales Q2Q%12.95%

3.2 Future

Based on estimates for the next years, AIM will show a very strong growth in Earnings Per Share. The EPS will grow by 26.37% on average per year.
The Revenue is expected to grow by 249.94% on average over the next years. This is a very strong growth
EPS Next Y88.78%
EPS Next 2Y40.94%
EPS Next 3Y26.37%
EPS Next 5YN/A
Revenue Next Year3579.55%
Revenue Next 2Y534.93%
Revenue Next 3Y249.94%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AIM.CA Yearly Revenue VS EstimatesAIM.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 500M 1B 1.5B 2B
AIM.CA Yearly EPS VS EstimatesAIM.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1 -2

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AIM. In the last year negative earnings were reported.
Also next year AIM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AIM.CA Price Earnings VS Forward Price EarningsAIM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AIM is valued a bit cheaper than the industry average as 74.19% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.65
AIM.CA Per share dataAIM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

AIM's earnings are expected to grow with 26.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.94%
EPS Next 3Y26.37%

0

5. Dividend

5.1 Amount

No dividends for AIM!.
Industry RankSector Rank
Dividend Yield N/A

AIMIA INC

TSX:AIM (2/13/2025, 7:00:00 PM)

2.43

-0.02 (-0.82%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-08 2024-11-08/bmo
Earnings (Next)N/A N/A
Inst Owners31.54%
Inst Owner ChangeN/A
Ins Owners1.08%
Ins Owner ChangeN/A
Market Cap232.67M
Analysts83.33
Price Target4.21 (73.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.14
Dividend Growth(5Y)N/A
DP-14.99%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)29.55%
Min EPS beat(2)-15.51%
Max EPS beat(2)74.61%
EPS beat(4)2
Avg EPS beat(4)-110.07%
Min EPS beat(4)-583.17%
Max EPS beat(4)83.8%
EPS beat(8)2
Avg EPS beat(8)-670.6%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)3.13%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)100%
EPS NY rev (1m)0%
EPS NY rev (3m)21.88%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.71%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.49
P/FCF N/A
P/OCF N/A
P/B 0.43
P/tB 1.65
EV/EBITDA 19.65
EPS(TTM)-0.95
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)-0.35
FCFYN/A
OCF(TTM)-0.21
OCFYN/A
SpS4.95
BVpS5.66
TBVpS1.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.58%
ROE -17.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.11%
FCFM N/A
ROA(3y)8.54%
ROA(5y)43.4%
ROE(3y)4.19%
ROE(5y)52.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-22.29%
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Debt/EBITDA 10.67
Cap/Depr 38.89%
Cap/Sales 2.96%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.73
Quick Ratio 2.06
Altman-Z -1.79
F-Score5
WACC8.12%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.08%
EPS Next Y88.78%
EPS Next 2Y40.94%
EPS Next 3Y26.37%
EPS Next 5YN/A
Revenue 1Y (TTM)133.58%
Revenue growth 3Y340.8%
Revenue growth 5Y11.75%
Sales Q2Q%12.95%
Revenue Next Year3579.55%
Revenue Next 2Y534.93%
Revenue Next 3Y249.94%
Revenue Next 5YN/A
EBIT growth 1Y-5.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year124.87%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-168.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-57.14%
OCF growth 3YN/A
OCF growth 5YN/A